MindMaze Therapeutics
V6M.F
#11193
Rank
C$2.86 M
Marketcap
C$0.22
Share price
-1.39%
Change (1 day)
N/A
Change (1 year)

EPS for MindMaze Therapeutics (V6M.F)

EPS in 2024: C-$2.17

According to MindMaze Therapeutics's latest financial reports the company's current EPS (TTM) is C-$2.17. In 2024 the company made an earnings per share (EPS) of C-$2.17 an increase over its 2023 EPS that were of C-$14.25.

EPS history for MindMaze Therapeutics from 2007 to 2024

Annual EPS

Year EPS Change
2024C-$2.17-84.79%
2023C-$14.2591.03%
2022C-$7.4618.81%
2021C-$6.28221.62%
2020C-$1.95-17.59%
2019C-$2.371809.94%
2018C-$0.12-78.95%
2017C-$0.59-91.95%
2016C-$7.329029.37%
2015C-$0.08018-99.45%
2014C-$14.65-68.12%
2013C-$45.95292.43%
2012C-$11.71-97.77%
2011C-$524.93192.88%
2010C-$179.231332.73%
2009C-$12.51-84.42%
2008C-$80.28956.49%
2007C-$7.60